Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (62462) 62462
Book Chapter (226) 226
Newspaper Article (225) 225
Magazine Article (78) 78
Book / eBook (51) 51
Newsletter (44) 44
Government Document (33) 33
Dissertation (25) 25
Conference Proceeding (20) 20
Publication (16) 16
Reference (5) 5
Report (3) 3
Web Resource (3) 3
Paper (2) 2
Book Review (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (56540) 56540
female (50626) 50626
science & technology (49185) 49185
life sciences & biomedicine (44746) 44746
breast cancer (38890) 38890
oncology (30080) 30080
breast neoplasms - pathology (25781) 25781
middle aged (24945) 24945
adult (18521) 18521
aged (18241) 18241
tumors (16385) 16385
cancer (16364) 16364
metastasis (12365) 12365
breast neoplasms - drug therapy (11782) 11782
biological and medical sciences (11602) 11602
medical sciences (11183) 11183
cell line, tumor (10519) 10519
animals (10042) 10042
breast neoplasms - metabolism (9687) 9687
research (9269) 9269
male (8437) 8437
breast neoplasms - genetics (8311) 8311
care and treatment (8155) 8155
prognosis (7805) 7805
chemotherapy (7801) 7801
health aspects (7053) 7053
mice (7021) 7021
analysis (6867) 6867
gene expression (6670) 6670
medicine & public health (6570) 6570
proteins (6492) 6492
aged, 80 and over (6458) 6458
gynecology. andrology. obstetrics (6451) 6451
research article (6416) 6416
cancer therapies (6310) 6310
mammary gland diseases (6199) 6199
surgery (6128) 6128
breast neoplasms - surgery (5943) 5943
apoptosis (5593) 5593
treatment outcome (5570) 5570
risk factors (5499) 5499
medicine (5343) 5343
genetic aspects (4870) 4870
immunohistochemistry (4712) 4712
bone neoplasms - secondary (4702) 4702
breast neoplasms - therapy (4643) 4643
neoplasm staging (4635) 4635
cell biology (4520) 4520
retrospective studies (4438) 4438
science & technology - other topics (4378) 4378
development and progression (4362) 4362
medical prognosis (4344) 4344
metastases (4316) 4316
breast neoplasms - mortality (4300) 4300
studies (4265) 4265
gene expression regulation, neoplastic (4229) 4229
patients (4215) 4215
kinases (4213) 4213
breast neoplasms - diagnosis (4169) 4169
abridged index medicus (4130) 4130
multidisciplinary sciences (4102) 4102
cell proliferation (3826) 3826
pathology (3744) 3744
neoplasm metastasis (3727) 3727
signal transduction (3720) 3720
follow-up studies (3584) 3584
lymphatic metastasis (3584) 3584
science (3519) 3519
antineoplastic combined chemotherapy protocols - therapeutic use (3494) 3494
diagnosis (3433) 3433
medical research (3362) 3362
cell cycle (3336) 3336
neoplasms. tumors. oncology. including cancer and carcinogens (3271) 3271
cell growth (3137) 3137
oncology, experimental (3125) 3125
biochemistry & molecular biology (3116) 3116
hematology, oncology and palliative medicine (3062) 3062
cancer research (3016) 3016
breast neoplasms (2880) 2880
antineoplastic agents - therapeutic use (2848) 2848
lung neoplasms - secondary (2836) 2836
antineoplastic agents (2795) 2795
time factors (2736) 2736
skin and connective tissue diseases (2729) 2729
disease-free survival (2726) 2726
mutation (2698) 2698
neoplasm invasiveness (2663) 2663
mastectomy (2606) 2606
radiology, nuclear medicine & medical imaging (2580) 2580
pharmacology. drug treatments (2564) 2564
clinical trials (2550) 2550
cell proliferation - drug effects (2528) 2528
breast neoplasms - secondary (2461) 2461
breast (2458) 2458
mcf-7 cells (2443) 2443
survival analysis (2440) 2440
survival rate (2437) 2437
breast neoplasms - radiotherapy (2431) 2431
quality of life (2427) 2427
mice, nude (2410) 2410
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (14) 14
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (9) 9
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Online Resources - Online (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Gerstein Science - Circulation Desk (2) 2
St. Michael's Hospital - Stacks (2) 2
Women's College Hospital - Stacks (2) 2
Sunnybrook Health Sciences Centre - Holland Stacks (1) 1
Women's College Hospital - Online (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (60655) 60655
Japanese (785) 785
German (673) 673
French (602) 602
Spanish (297) 297
Chinese (240) 240
Russian (206) 206
Italian (185) 185
Portuguese (129) 129
Polish (102) 102
Dutch (61) 61
Danish (54) 54
Czech (51) 51
Hungarian (51) 51
Norwegian (20) 20
Romanian (17) 17
Bulgarian (14) 14
Hebrew (14) 14
Serbian (11) 11
Swedish (10) 10
Finnish (9) 9
Korean (7) 7
Turkish (7) 7
Croatian (4) 4
Slovak (4) 4
Lithuanian (3) 3
Greek (2) 2
Ukrainian (2) 2
Latvian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors
by Vargas, G and Bouchet, M and Bouazza, L and Reboul, P and Boyault, C and Gervais, M and Kan, C and Benetollo, C and Brevet, M and Croset, M and Mazel, M and Cayrefourcq, L and Geraci, S and Vacher, S and Pantano, F and Filipits, M and Driouch, K and Bieche, I and Gnant, M and Jacot, W and Aubin, J.E and Duterque-Coquillaud, M and Alix-Panabières, C and Clézardin, P and Bonnelye, E
Oncogene, ISSN 0950-9232, 02/2019, Volume 38, Issue 7, pp. 950 - 964
Biochemistry & Molecular Biology | Oncology | Genetics & Heredity | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Receptors, Estrogen - metabolism | Receptors, Estrogen - genetics | Humans | Gene Expression Regulation, Neoplastic | Bone Neoplasms - secondary | Neoplasm Proteins - metabolism | Bone Neoplasms - pathology | Bone Neoplasms - metabolism | Breast Neoplasms - metabolism | Mammary Neoplasms, Animal - pathology | Animals | Breast Neoplasms - genetics | Receptor Activator of Nuclear Factor-kappa B - biosynthesis | Breast Neoplasms - pathology | Mammary Neoplasms, Animal - metabolism | Receptor Activator of Nuclear Factor-kappa B - genetics | Female | Bone Neoplasms - genetics | Mice | Mice, Inbred BALB C | Neoplasm Proteins - genetics | Mammary Neoplasms, Animal - genetics | TOR protein | Phosphorylation | Tumor cells | Invasiveness | Therapeutic applications | Breast cancer | Bone tumors | Metastasis | Kinases | Metastases | Bone growth | Bone cancer | Skeleton | TRANCE protein | Bioinformatics | Tumors | Index Medicus | Breast Neoplasms/pathology | Mammary Neoplasms, Animal/genetics | Genomics | Bone Neoplasms/secondary | Receptors, Estrogen/metabolism | Life Sciences | Mammary Neoplasms, Animal/pathology | Mammary Neoplasms, Animal/metabolism | Receptor Activator of Nuclear Factor-kappa B/genetics | Neoplasm Proteins/genetics | Neoplasm Proteins/metabolism | Receptor Activator of Nuclear Factor-kappa B/biosynthesis | Receptors, Estrogen/genetics | Biochemistry, Molecular Biology | Bone Neoplasms/metabolism | Bone Neoplasms/genetics | Bone Neoplasms/pathology | Breast Neoplasms/genetics | Breast Neoplasms/metabolism | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Concurrent irradiation with the anti-programmed cell death ligand-1 immune checkpoint blocker durvalumab: Single centre subset analysis from a phase 1/2 trial
by Levy, Antonin and Massard, Christophe and Soria, Jean-Charles and Deutsch, Eric
European journal of cancer (1990), ISSN 0959-8049, 2016, Volume 68, pp. 156 - 162
Hematology, Oncology and Palliative Medicine | Immunoradiotherapy | Phase 2 | Phase 1 | Radiotherapy | Anti-PD-L1 | Life Sciences & Biomedicine | Oncology | Science & Technology | Lymphatic Metastasis - radiotherapy | Bone Neoplasms - therapy | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | Radiosurgery | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Carcinoma, Transitional Cell - therapy | Liver Neoplasms - therapy | Eye Neoplasms - therapy | Chemoradiotherapy | Small Cell Lung Carcinoma - secondary | Breast Neoplasms - therapy | Brain Neoplasms - secondary | Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Adult | Female | Liver Neoplasms - secondary | Colonic Neoplasms - therapy | Eye Neoplasms - pathology | Head and Neck Neoplasms - therapy | Kaplan-Meier Estimate | Carcinoma, Squamous Cell - therapy | Survival Rate | Lung Neoplasms - therapy | Adenocarcinoma - secondary | Melanoma - secondary | Head and Neck Neoplasms - pathology | Disease-Free Survival | B7-H1 Antigen - antagonists & inhibitors | Adenocarcinoma - therapy | Breast Neoplasms - pathology | Colonic Neoplasms - pathology | Urinary Bladder Neoplasms - therapy | Brain Neoplasms - therapy | Radiotherapy, Conformal | Aged | Small Cell Lung Carcinoma - therapy | Melanoma - therapy | Biochemistry | Apoptosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors
by Naoki Niikura and Jun Liu and Naoki Hayashi and Elizabeth A. Mittendorf and Yun Gong and Shana L. Palla and Yutaka Tokuda and Ana M. Gonzalez-Angulo and Gabriel N. Hortobagyi and Naoto T. Ueno
Journal of clinical oncology, ISSN 0732-183X, 02/2012, Volume 30, Issue 6, pp. 593 - 599
Life Sciences & Biomedicine | Oncology | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Biological and medical sciences | Medical sciences | Tumors | Humans | Lung Neoplasms - metabolism | Middle Aged | Receptor, ErbB-2 - metabolism | Bone Neoplasms - secondary | Antineoplastic Agents - therapeutic use | Brain Neoplasms - metabolism | Bone Neoplasms - metabolism | Breast Neoplasms - metabolism | Young Adult | Brain Neoplasms - secondary | Neoplasm Grading | Lung Neoplasms - secondary | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Retrospective Studies | Liver Neoplasms - secondary | Antibodies, Monoclonal, Humanized - therapeutic use | Survival Rate | Lymphatic Metastasis | Breast Neoplasms - drug therapy | Skin Neoplasms - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Liver Neoplasms - metabolism | Skin Neoplasms - secondary | Breast Neoplasms - mortality | Aged | Neoplasm Staging | Trastuzumab | Index Medicus | Bc2 | Original Reports
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Randomized Phase II Trial of First-Line Trastuzumab Plus Docetaxel and Capecitabine Compared With Trastuzumab Plus Docetaxel in HER2-Positive Metastatic Breast Cancer
by Andrew M. Wardley and Xavier Pivot and Flavia Morales-Vasquez and Luis M. Zetina and Maria de Fátima Dias Gaui and Douglas Otero Reyes and Jacek Jassem and Claire Barton and Peter Button and Veronica Hersberger and Antonio Antón Torres
Journal of clinical oncology, ISSN 0732-183X, 02/2010, Volume 28, Issue 6, pp. 976 - 983
Life Sciences & Biomedicine | Oncology | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Biological and medical sciences | Medical sciences | Tumors | Prognosis | Receptor, ErbB-2 - genetics | Capecitabine | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Bone Neoplasms - secondary | Soft Tissue Neoplasms - drug therapy | Bone Neoplasms - metabolism | Breast Neoplasms - metabolism | Feasibility Studies | Young Adult | Antibodies, Monoclonal, Humanized | Fluorouracil - administration & dosage | Aged, 80 and over | Adult | Female | Bone Neoplasms - drug therapy | Liver Neoplasms - secondary | Fluorouracil - analogs & derivatives | Soft Tissue Neoplasms - secondary | Deoxycytidine - administration & dosage | Liver Neoplasms - drug therapy | Soft Tissue Neoplasms - metabolism | In Situ Hybridization, Fluorescence | Survival Rate | Treatment Outcome | Breast Neoplasms - drug therapy | Taxoids - administration & dosage | International Agencies | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Liver Neoplasms - metabolism | Aged | Neoplasm Staging | Deoxycytidine - analogs & derivatives | Trastuzumab | Index Medicus | Liver Neoplasms | Breast Neoplasms | Life Sciences | Immunology | Taxoids | Fluorouracil | Antineoplastic Combined Chemotherapy Protocols | Antibodies, Monoclonal | Bone Neoplasms | Receptor, erbB-2 | Deoxycytidine | Soft Tissue Neoplasms
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
by Sakai, Wataru and Swisher, Elizabeth M and Karlan, Beth Y and Agarwal, Mukesh K and Higgins, Jake and Friedman, Cynthia and Villegas, Emily and Jacquemont, Céline and Farrugia, Daniel J and Couch, Fergus J and Urban, Nicole and Taniguchi, Toshiyasu
Nature (London), ISSN 0028-0836, 02/2008, Volume 451, Issue 7182, pp. 1116 - 1120
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Chemotherapy | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antineoplastic agents | Tumors | Azulenes - pharmacology | Benzodiazepines - pharmacology | Humans | Middle Aged | Pancreatic Neoplasms - pathology | Pancreatic Neoplasms - genetics | Cisplatin - pharmacology | Mutation - genetics | Breast Neoplasms - drug therapy | Poly(ADP-ribose) Polymerase Inhibitors | Neoplasms - drug therapy | Ovarian Neoplasms - genetics | Pancreatic Neoplasms - drug therapy | Drug Resistance, Neoplasm - genetics | BRCA2 Protein - metabolism | Breast Neoplasms - genetics | Neoplasms - genetics | Breast Neoplasms - pathology | Cell Line, Tumor | Genes, BRCA2 | Female | Ovarian Neoplasms - drug therapy | BRCA2 Protein - genetics | Drug Resistance, Neoplasm - drug effects | Breast cancer | Mutation | Drug resistance | Pancreatic cancer | Ovarian cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text αv‐Integrin isoform expression in primary human tumors and brain metastases
by Vogetseder, Alexander and Thies, Svenja and Ingold, Barbara and Roth, Patrick and Weller, Michael and Schraml, Peter and Goodman, Simon L and Moch, Holger
International journal of cancer, ISSN 0020-7136, 11/2013, Volume 133, Issue 10, pp. 2362 - 2371
integrin | brain metastases | cilengitide | Life Sciences & Biomedicine | Oncology | Science & Technology | Neurology | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors of the nervous system. Phacomatoses | Tumors | Neoplasms - metabolism | Breast Neoplasms - secondary | Integrin alphaV - biosynthesis | Kidney Neoplasms - genetics | Humans | Lung Neoplasms - metabolism | Brain Neoplasms - pathology | Lung Neoplasms - pathology | Kidney Neoplasms - metabolism | Brain Neoplasms - metabolism | Breast Neoplasms - metabolism | Brain Neoplasms - secondary | Neoplasm Metastasis | Lung Neoplasms - secondary | Neoplasms - genetics | Melanoma - genetics | Female | Integrin alphaV - genetics | Integrin alphaV - metabolism | Lung Neoplasms - genetics | Melanoma - metabolism | Brain Neoplasms - genetics | Melanoma - pathology | Melanoma - secondary | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Protein Isoforms | Kidney Neoplasms - pathology | Kidney Neoplasms - secondary | Neoplasms - pathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Metastases to nasal cavity and paranasal sinuses
by López, Fernando and Devaney, Kenneth O and Hanna, Ehab Y and Rinaldo, Alessandra and Ferlito, Alfio and Eisele, David W
Head & neck, ISSN 1043-3074, 12/2016, Volume 38, Issue 12, pp. 1847 - 1854
sinonasal cavities | metastases | maxillary sinus | paranasal sinuses | nasal cavity | Otorhinolaryngology | Life Sciences & Biomedicine | Surgery | Science & Technology | Bone Neoplasms - mortality | Prognosis | Bone Neoplasms - therapy | Lung Neoplasms - mortality | Humans | Lung Neoplasms - pathology | Male | Liver Neoplasms - therapy | Liver Neoplasms - mortality | Bone Neoplasms - pathology | Prostatic Neoplasms - therapy | Breast Neoplasms - therapy | Thyroid Neoplasms - therapy | Nasal Cavity - pathology | Female | Liver Neoplasms - pathology | Kidney Neoplasms - therapy | Paranasal Sinus Neoplasms - therapy | Prostatic Neoplasms - pathology | Thyroid Neoplasms - mortality | Risk Assessment | Carcinoma, Renal Cell - pathology | Lung Neoplasms - therapy | Kidney Neoplasms - mortality | Maxillary Sinus Neoplasms - mortality | Prostatic Neoplasms - mortality | Paranasal Sinus Neoplasms - mortality | Carcinoma, Renal Cell - mortality | Breast Neoplasms - pathology | Survival Analysis | Carcinoma, Renal Cell - therapy | Breast Neoplasms - mortality | Kidney Neoplasms - pathology | Paranasal Sinus Neoplasms - secondary | Maxillary Sinus Neoplasms - therapy | Maxillary Sinus Neoplasms - secondary | Thyroid Neoplasms - pathology | Radiotherapy | Metastasis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Metastatic progression of breast cancer: insights from 50 years of autopsies
by Cummings, Margaret C and Simpson, Peter T and Reid, Lynne E and Jayanthan, Janani and Skerman, Joanna and Song, Sarah and McCart Reed, Amy E and Kutasovic, Jamie R and Morey, Adrienne L and Marquart, Louise and O'Rourke, Peter and Lakhani, Sunil R
The Journal of pathology, ISSN 0022-3417, 01/2014, Volume 232, Issue 1, pp. 23 - 31
treatment | breast cancer | pathology | intratumour heterogeneity | metastasis | autopsy | Pathology | Oncology | Life Sciences & Biomedicine | Science & Technology | Bone Neoplasms - mortality | Age Factors | Oligonucleotide Array Sequence Analysis | Lung Neoplasms - mortality | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Bone Neoplasms - secondary | Gene Expression Profiling | Liver Neoplasms - mortality | Central Nervous System Neoplasms - secondary | DNA Copy Number Variations | Lung Neoplasms - secondary | Autopsy | Biomarkers, Tumor - metabolism | Female | Bone Neoplasms - genetics | Retrospective Studies | Liver Neoplasms - secondary | Genital Neoplasms, Female - genetics | Lung Neoplasms - genetics | Liver Neoplasms - genetics | Central Nervous System Neoplasms - genetics | Lymphatic Metastasis | Queensland - epidemiology | Disease Progression | Genital Neoplasms, Female - mortality | Breast Neoplasms - genetics | Comparative Genomic Hybridization | Breast Neoplasms - pathology | Genital Neoplasms, Female - secondary | Breast Neoplasms - mortality | Central Nervous System Neoplasms - mortality | Cohort Studies | Index Medicus | Original Papers
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights